CLINICAL VALUE OF SUPAR, A NEW BIOMARKER

被引：0
|
作者：
Donadello, K. [1 ]
Covajes, C. [1 ]
Scolletta, S. [1 ]
Taccone, F. S. [1 ]
Santonocito, C. [1 ]
Brimioulle, S. [1 ]
Beumier, M. [1 ]
Van Nuffelen, M. [1 ]
Gottin, L. [2 ]
Vincent, J-L [1 ]
机构：
[1] Erasme Univ Hosp, B-1070 Brussels, Belgium
[2] Policlin Univ GB Rossi, Verona, Italy
来源：
INTENSIVE CARE MEDICINE | 2011年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
0775
引用
收藏
页码：S199 / S199
页数：1
相关论文
共 50 条
  • [21] suPAR as a biomarker for risk of readmission and mortality in the acute medical setting
    Nayak, Raj Kumar
    Allingstrup, Mikkel
    Phanareth, Klaus
    Kofoed-Enevoldsen, Allan
    DANISH MEDICAL JOURNAL, 2015, 62 (10):
  • [22] Circulating suPAR as a biomarker of disease severity in children with proteinuric glomerulonephritis
    Soltysiak, Jolanta
    Zachwieja, Jacek
    Benedyk, Anna
    Lewandowska-Stachowiak, Maria
    Nowicki, Michal
    Ostalska-Nowicka, Danuta
    MINERVA PEDIATRICA, 2019, 71 (01) : 4 - 11
  • [23] STRATIFICATION AND PARTIAL ASCERTAINMENT OF BIOMARKER VALUE IN BIOMARKER-DRIVEN CLINICAL TRIALS
    Simon, Richard
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2014, 24 (05) : 1011 - 1021
  • [24] Clinical value of Alzheimer's disease biomarker testing
    Patel, Khushbu J.
    Yang, David
    Best, John R.
    Chambers, Colleen
    Lee, Philip E.
    Henri-Bhargava, Alexandre
    Funnell, Clark R.
    Foti, Dean J.
    Pettersen, Jacqueline A.
    Feldman, Howard H.
    Nygaard, Haakon B.
    Hsiung, Ging-Yuek R.
    DeMarco, Mari L.
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2024, 10 (02)
  • [25] Copeptin:: clinical use of a new biomarker
    Morgenthaler, Nils G.
    Struck, Joachim
    Jochberger, Stefan
    Duenser, Martin W.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2008, 19 (02): : 43 - 49
  • [26] CAN SUPAR BE USED AS A BIOMARKER OF INFLAMMATION IN THE BLOOD DONOR QUALIFICATION PROCESS?
    Klausa, E.
    Swiatek, E.
    Kozlowski, R.
    VOX SANGUINIS, 2012, 103 : 93 - 93
  • [27] IS CIRCULATING SUPAR A POTENTIAL BIOMARKER OF LUPUS NEPHRITIS IN CHILDREN WITH NEPHROTIC PROTEINURIA?
    Soltysiak, Jolanta
    Silska-Dittmar, Magdalena
    Ostalska-Nowicka, Danuta
    Lewandowska-Stachowiak, Maria
    Zachwieja, Jacek
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [28] The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine Perspective
    Benucci, Maurizio
    Damiani, Arianna
    Russo, Edda
    Guiducci, Serena
    Li Gobbi, Francesca
    Fusi, Paola
    Grossi, Valentina
    Amedei, Amedeo
    Manfredi, Mariangela
    Infantino, Maria
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (12):
  • [29] Measurement of serum suPAR is not ready for clinical use
    Jeroen Deegens
    Jack Wetzels
    Nature Reviews Nephrology, 2014, 10 : 610 - 610
  • [30] Prognostic value of suPAR and hs-CRP on cardiovascular disease
    Diederichsen, Marie Zoga
    Diederichsen, Soren Zoga
    Mickley, Hans
    Steffensen, Flemming Hald
    Lambrechtsen, Jess
    Sand, Niels Peter Ronnow
    Christensen, Kent Lodberg
    Olsen, Michael Hecht
    Diederichsen, Axel
    Gronhoj, Mette Hjortdal
    ATHEROSCLEROSIS, 2018, 271 : 245 - 251
12345